InsidersTradesSigma
Explore the detailed record of transactions filed by Dentzer James E, Chairman & CEO. Insider active across 1 companies, notably CURIS INC. Aggregated, 2 reports have been published. Total volume traded: €14k. The latest transaction was filed on 27 January 2022 — Cession. Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
James E. Dentzer is the President and CEO of Curis Inc. He leads the company in its efforts to develop innovative oncology treatments. His strategic vision and leadership are crucial to the company's mission.